Clinical Feasibility of 5.0 T MRI/MRCP in Characterizing Pancreatic Cystic Lesions: Comparison with 3.0 T and MDCT

Area of Science:

• Radiology and Imaging Science
• Gastrointestinal Imaging
• Medical Physics

Background:

• Pancreatic cystic lesions (PCLs) present diagnostic challenges.
• Current imaging modalities like multidetector computed tomography (MDCT) and 3.0 Tesla (T) magnetic resonance imaging (MRI) have limitations in characterizing PCLs.
• Higher field strength MRI may offer improved image quality and diagnostic performance.

Purpose of the Study:

• To evaluate the feasibility and diagnostic performance of 5.0 T MRI for characterizing PCLs.
• To compare 5.0 T MRI with 3.0 T MRI and MDCT in terms of image quality and diagnostic accuracy.
• To assess the ability of 5.0 T MRI to differentiate benign from malignant PCLs and provide specific diagnoses.

Main Methods:

• Thirty-five patients with PCLs underwent imaging with 5.0 T MRI, alongside either 3.0 T MRI or MDCT.
• Subjective and objective image quality scores were assessed by two independent observers.
• Image analysis included lesion characterization, diagnosis, and assessment of benignity/malignancy.

Main Results:

• 5.0 T MRI demonstrated significantly higher subjective image quality and signal-to-noise ratio (SNR) on T1-weighted images compared to 3.0 T MRI.
• 5.0 T MRI detected more cystic lesions than 3.0 T MRI and MDCT.
• 5.0 T MRI achieved superior sensitivity (75%), specificity (100%), and accuracy (91.4%) in differentiating benign from malignant lesions, outperforming 3.0 T MRI and MDCT. Specific diagnostic accuracy was also higher at 80%.

Conclusions:

• 5.0 T MRI shows superiority in delineating PCL details and enhancing clinical diagnostic accuracy.
• This advanced MRI technique outperforms MDCT and 3.0 T MRI for PCL characterization.
• 5.0 T MRI maintains sufficient image quality for clinical application in evaluating pancreatic cystic lesions.